Sfoglia per AUTORE
ZIGNEGO AL
Collezione AOU Città della Salute di Torino

  

Items : 11

A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2024 Sep;146:107115. doi: 10.1016/j.ijid.2024.107115. Epub 2024 May 26.
2024
AOU Città della Salute di Torino

Surace L; Bassetti M; Toniutto P; Gentile I; Chemello L; Madonia S; Rosselli Del Turco E; Milella M; Chessa L; Soria A; Maida I; Foschi FG; Rocco A; Ieluzzi D; Federico A; Morsica G; Marrone A; Blanc P; Di Marco V; Laccabue D; Ferrarese A; Russo FP; Massari M; Viganò M; Fagiuoli S; Barchiesi F; Stanzione M; Coppola N; Barbaro F; et alii...

Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort. in United European gastroenterology journal / United European Gastroenterol J. 2024 Apr;12(3):352-363. doi: 10.1002/ueg2.12496. Epub 2023 Nov 30.
2024
AOU Città della Salute di Torino

Benedetti A; Brancaccio G; Invernizzi P; Giacometti A; Chessa L; Piscaglia F; Pompili M; Ciancio A; Persico M; Cerini F; Federico A; Licata A; Barbaro F; Morisco F; Coppola C; Cavalletto L; Chemello L; Madonia S; Iannone A; Ieluzzi D; Biliotti E; Raimondo G; Brunetto MR; Calvaruso V; Zignego AL; Panetta V; Ferrigno L; Quaranta MG; Kondili LA; et alii...

Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2023 Jul;55(7):907-917. doi: 10.1016/j.dld.2023.01.153. Epub 2023 Feb 10.
2023
AOU Città della Salute di Torino

Puoti M; Santantonio T; Viganò M; Pompili M; Morisco F; Russo FP; Persico M; Barbaro F; Licata A; Massari M; Verucchi G; Biliotti E; Coppola C; Iannone A; Zignego AL; Brunetto MR; Raimondo G; Brancaccio G; Simonelli I; D'Ambrosio R; Ferrigno L; Calvaruso V; Cavalletto L; Quaranta MG; Kondili LA; Villa E; Craxì A; Chemello L;

2023
AOU Città della Salute di Torino

Ferri C; Raimondo V; Giuggioli D; Gragnani L; Lorini S; Dagna L; Bosello SL; Foti R; Riccieri V; Guiducci S; Cuomo G; Tavoni A; De Angelis R; Cacciapaglia F; Zanatta E; Cozzi F; Murdaca G; Cavazzana I; Romeo N; Codullo V; Pellegrini R; Varcasia G; De Santis M; Selmi C; Abignano G; Caminiti M; L'Andolina M; Olivo D; Lubrano E; et alii...

Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2023 Apr;129:266-273. doi: 10.1016/j.ijid.2023.02.006. Epub 2023 Feb 13.
2023
AOU Città della Salute di Torino

Craxì A; Di Marco V; Lampertico P; Ferrari C; Marzano A; Fagiuoli S; Madonia S; Chemello L; Puoti M; Zignego AL; Verucchi G; Claar E; Blanc P; Coppola N; Russo FP; Ciancio A; Barbaro F; Milella M; Chessa L; Morisco F; Messina V; Cacciola I; Ferrigno L; Tosti ME; Quaranta MG; Nardi A; Brancaccio G; Coco B; Santantonio TA; et alii...

A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort. in Hepatology (Baltimore, Md.) / Hepatology. 2022 Jul;76(1):220-232. doi: 10.1002/hep.32281. Epub 2022 Jan 19.
2022
AOU Città della Salute di Torino

Russo FP; Ciancio A; Iannone A; Chemello L; Coco B; Verucchi G; Benedetti A; Rumi MG; Coppola C; Ieluzzi D; Laccabue D; Fracanzani AL; Filomia R; Puoti M; Biliotti E; Madonia S; Andreone P; Gentile I; Masarone M; Persico M; Mazzaro C; Brancaccio G; Panetta V; Gragnani L; Quaranta MG; Kondili LA; Monti M; Barbaro F; Morisco F; et alii...

Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Dec 10;40(35):4060-4070. doi: 10.1200/JCO.22.00668. Epub 2022 Jun 17.
2022
AOU Città della Salute di Torino

Passamonti F; Marcheselli L; Zignego AL; Visco C; Russo F; Chimienti E; Zuccaro V; Sacchi P; Santoro A; Pulsoni A; Vallisa D; Dodero A; Perbellini O; Ferreri AJM; Orsucci L; Piazza F; Re F; Motta M; Rattotti S; Spina M; Merli M; Luminari S; Paulli M; Bruno R; Arcaini L;

Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies. in Current pharmaceutical design / Curr Pharm Des. 2022;28(24):2022-2028. doi: 10.2174/1381612828666220614151732.
2022
AOU Città della Salute di Torino

Ferri C; Raimondo V; Gragnani L; Giuggioli D; Dagna L; Tavoni A; Ursini F; L'Andolina M; Caso F; Ruscitti P; Caminiti M; Foti R; Riccieri V; Guiducci S; Pellegrini R; Zanatta E; Varcasia G; Olivo D; Gigliotti P; Cuomo G; Murdaca G; Cecchetti R; De Angelis R; Romeo N; Ingegnoli F; Cozzi F; Codullo V; Cavazzana I; Colaci M; et alii...

Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2021 May;53(5):612-619. doi: 10.1016/j.dld.2020.08.007. Epub 2020 Sep 8.
2021
AOU Città della Salute di Torino
AOU Novara

Zignego AL; Roscini AS; Gualberti G; De Michina A; Gallinaro V; Villa E; Vinci M; Schiavini M; Serviddio G; Sangiovanni V; Russello M; Romano A; Raimondo G; Puoti M; Pirisi M; Morisco F; Persico M; Milella M; Lichtner M; Lampertico P; Giorgini A; Grilli E; Gasbarrini A; Galli M; Gaeta GB; Ciancio A; Craxì A; Brunetto MR; Chessa L; et alii...

Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments. in Current pharmaceutical design / Curr Pharm Des. 2021;27(41):4245-4252. doi: 10.2174/1381612827666210903103935.
2021
AOU Città della Salute di Torino

Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Dagna L; Tavoni A; Caso F; Ursini F; Ruscitti P; Caminiti M; Foti R; Riccieri V; Guiducci S; Pellegrini R; Zanatta E; Varcasia G; Olivo D; Gigliotti P; Cuomo G; Murdaca G; Cecchetti R; De Angelis R; Romeo N; Ingegnoli F; Cozzi F; Codullo V; Cavazzana I; Colaci M; Abignano G; et alii...

Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2018 Dec;38(12):2190-2198. doi: 10.1111/liv.13901. Epub 2018 Aug 10.
2018
AOU Città della Salute di Torino

Kondili LA; Robbins S; Blach S; Gamkrelidze I; Zignego AL; Brunetto MR; Raimondo G; Taliani G; Iannone A; Russo FP; Santantonio TA; Zuin M; Chessa L; Blanc P; Puoti M; Vinci M; Erne EM; Strazzabosco M; Massari M; Lampertico P; Rumi MG; Federico A; Orlandini A; Ciancio A; Borgia G; Andreone P; Caporaso N; Persico M; Ieluzzi D; et alii...